39 related articles for article (PubMed ID: 16024624)
21. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
22. CaSm: an Sm-like protein that contributes to the transformed state in cancer cells.
Schweinfest CW; Graber MW; Chapman JM; Papas TS; Baron PL; Watson DK
Cancer Res; 1997 Jul; 57(14):2961-5. PubMed ID: 9230209
[TBL] [Abstract][Full Text] [Related]
23. The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer.
Kelley JR; Brown JM; Frasier MM; Baron PL; Schweinfest CW; Vournakis JN; Watson DK; Cole DJ
Surgery; 2000 Aug; 128(2):353-60. PubMed ID: 10923016
[TBL] [Abstract][Full Text] [Related]
24. Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.
Yan Y; Rubinchik S; Watson PM; Kelley JR; Fraser MM; Wood AL; Dong JY; Gillanders WE; Boylan AM; Watson DK; Cole DJ
Mol Ther; 2005 Mar; 11(3):363-72. PubMed ID: 15727932
[TBL] [Abstract][Full Text] [Related]
25. The genetic/metabolic transformation concept of carcinogenesis.
Costello LC; Franklin RB
Cancer Metastasis Rev; 2012 Jun; 31(1-2):123-30. PubMed ID: 22109079
[TBL] [Abstract][Full Text] [Related]
26. Oncomodulin in normal and transformed cells.
MacManus JP; Brewer LM; Banville D
Adv Exp Med Biol; 1990; 269():107-10. PubMed ID: 2191548
[No Abstract] [Full Text] [Related]
27. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
28. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer.
Kelley JR; Fraser MM; Hubbard JM; Watson DK; Cole DJ
Anticancer Res; 2003; 23(3A):2007-13. PubMed ID: 12894573
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle deregulation: a common motif in cancer.
Malumbres M; Carnero A
Prog Cell Cycle Res; 2003; 5():5-18. PubMed ID: 14593696
[TBL] [Abstract][Full Text] [Related]
30. Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: effects of mutations that result in autocrine growth stimulation and malignant transformation.
Wang XY; Steelman LS; McCubrey JA
Cytokines Cell Mol Ther; 1997 Mar; 3(1):3-19. PubMed ID: 9287239
[TBL] [Abstract][Full Text] [Related]
31. Cell damage, aging and transformation: a multilevel analysis of carcinogenesis.
Rubin H
Anticancer Res; 1999; 19(6A):4877-86. PubMed ID: 10697601
[TBL] [Abstract][Full Text] [Related]
32. The development of tumor cell characteristics.
Robertson DS
J Cell Physiol; 2014 Jun; 229(6):705-10. PubMed ID: 24590963
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
